Ac
Acerus (Sun)
Mississauga CAFounded 201040 employees
Private CapbiotechAcquiredEndocrinology
Platform: Natesto T
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ACE-3611 | ACE-3611 | NDA/BLA | 1 | CDK4/6 | EoEPancreatic Ca | ||
| Doxazasiran | ACE-6922 | Phase 2/3 | 2 | PLK4 | PSPMelanoma | ||
| Polavorutinib | ACE-3290 | Phase 3 | 3 | HER2 | ThymomaNASH |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (5)